Article

Overexpression of SETD7 is Associated with Progression of Ovarian Cancer

2024-06-19

Abstract excerpt

SETD7 is a member of the SET domain-containing lysine methyltransferase family and is a crucial component in the development and spread of a number of human cancers. However, the specific function of the SETD7 gene in ovarian cancer (OC) is still unclear. The purpose of this research was to elucidate the expression and role of SETD7 in OC. In comparison to normal controls, OC tissues (83%, 73/88) and cell lines ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: add0b6b9-f876-5979-bcce-39542b8c8762
DOI: 10.20944/preprints202312.1124.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Overexpression of SETD7 is Associated with Progression of Ovarian CancerDOI 10.20944/preprints202312.1124.v2Read

Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascadeSemantic proximity Read

SETD8 is a prognostic biomarker that contributes to stem-like cell properties in non-small cell lung cancer.Semantic proximity Read

Impact of SETD8/KMT5A Overexpression on Hepatocellular Carcinoma Progression and PrognosisSemantic proximity Read

Downregulated m⁵C Regulator NSUN6 Enhances Proliferation, Migration and affects immune regulation in Ovarian CancerSemantic proximity Read

Bioinformatics Analysis and Insights for The Role of COMMD7 in Hepatocellular CarcinomaSemantic proximity Read

Bioinformatics Analysis and Insights for the Role of COMMD7 in Hepatocellular CarcinomaSemantic proximity Read

Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinomaSemantic proximity Read

MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinomaSemantic proximity Read

The role of OIP5 in the carcinogenesis and progression of ovarian cancerSemantic proximity Read

SETD7 is a novel therapeutic target for multiple myeloma with t(11;14)+Semantic proximity Read

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.Semantic proximity Read

ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferationSemantic proximity Read